According to a study published online in JAMA Internal Medicine (1/12/15), seniors newly taking atypical antipsychotic medication had a higher risk of specific fractures and hospital visits following a fall. Specifically, adults over the age of 64 faced a 53 percent increased risk of falling.
The study involved an analysis of information from the Institute for Clinical Evaluative Sciences in Ontario, Canada. Seniors who received a new prescription for an atypical antipsychotic from June 1, 2003 and December 31, 2011 were compared with those who did not receive a prescription. The patients were followed for 90 days to determine if they had any hospital visits linked to falls and/or fractures.
Seniors newly taking an antipsychotic medication were more likely than those in the comparison group to suffer a fall and were also more likely to suffer a fracture. However, the cause of that link is unclear.
Eli Lilly has come under fire for Zyprexa before. In 2007, the company agreed to pay approximately $1.4 billion to settle lawsuits alleging patients developed serious side effects as a result of taking the medication.
READ MORE ZYPREXA LEGAL NEWS
“Because one of Zyprexa’s side effects is sedation, Eli Lilly directed its long-term care sales force to tell doctors that Zyprexa would help patients with sleep problems, behavioral issues, and dementia,” the Justice Department noted.
When the lawsuit was settled, Zyprexa was approved to treat schizophrenia and certain types of bipolar disorder, according to the Justice Department.